Clinical Trial Imaging Market 2025 to 2034
Clinical Trial Imaging Market 2025 to 2034
Clinical Trial Imaging Market (By Service: Clinical Trial Design and Consultation Services, Reading and Analytical Services, Project and Data Management, System and Technology Support Services; By Modality: Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography, Echocardiography, X-Ray, Other Modalities; By End-Use: Pharmaceutical Companies, Medical Device Manufacturers, Academic and Government Research Institutes, Biotechnology Companies, Contract Research Organizations, Other End-Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034.
Customisation Request
Revenue, 2025
USD 2.57 Bn
Forecast Year, 2034
USD 5.45 Bn
CAGR, 2025 - 2034
8.78%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global clinical trial imaging market, valued at USD 2.57B in 2025, is set to reach USD 5.45B by 2034, growing at a CAGR of 8.78%, driven by rising demand for advanced imaging solutions in drug development and clinical research.
Clinical Trial Imaging Market Size Analysis
Clinical Trial Imaging Market Size By Service 2025 to (USD Billion)
| Service | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial Design and Consultation Services | 6.66 | 6.96 | 7.18 | 7.67 | 8.15 | 8.86 | 8.79 | 9.12 | 9.37 | 9.67 | 9.73 |
| Reading and Analytical Services | 2.95 | 3.21 | 3.38 | 3.57 | 3.71 | 4.00 | 4.26 | 4.42 | 4.61 | 4.99 | 5.35 |
| Project and Data Management | 16.64 | 17.22 | 18.36 | 19.13 | 19.63 | 20.40 | 21.73 | 22.61 | 23.71 | 24.55 | 26.10 |
| System and Technology Support Services | 10.98 | 11.59 | 11.88 | 12.33 | 13.22 | 13.54 | 14.21 | 15.14 | 16.00 | 16.98 | 17.64 |
Clinical Trial Imaging Market Size By Modality 2025 to 2034 (USD Billion)
| Modality | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Computed Tomography | 1546.27 | 1841.76 | 2274.19 | 2837.14 | 3429.12 | 3923.79 | 4337.88 | 4885.12 | 5841.74 | 6781.82 |
| Ultrasound | 418.83 | 490.36 | 481.45 | 522.55 | 667.74 | 752.62 | 959.15 | 1197.96 | 1490.10 | 1593.28 |
| Magnetic Resonance Imaging | 113.38 | 128.56 | 155.26 | 144.93 | 104.72 | 121.44 | 140.47 | 168.67 | 196.91 | 566.01 |
| Positron Emission Tomography | 330.44 | 409.72 | 508.89 | 679.06 | 610.34 | 829.73 | 1052.76 | 1345.13 | 1852.86 | 2305.70 |
| Echocardiography | 2797.24 | 3278.05 | 3841.55 | 4391.96 | 5315.90 | 6333.38 | 7635.64 | 9085.82 | 10320.64 | 12021.55 |
| X-Ray | 874.90 | 1106.49 | 1421.14 | 1751.95 | 2125.81 | 2498.62 | 2777.79 | 3208.52 | 3396.27 | 3971.55 |
| Other Modalities | 1742.41 | 2094.13 | 2384.57 | 2827.61 | 3193.60 | 3684.32 | 4518.85 | 5387.92 | 6208.38 | 7246.05 |
Clinical Trial Imaging Market Size By End-Use 2025 to (USD Billion)
| End-Use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Companies | 8.29 | 8.96 | 9.44 | 9.93 | 10.17 | 10.39 | 10.87 | 11.21 | 11.50 | 11.96 | 12.91 |
| Medical Device Manufacturers | 6.45 | 6.71 | 7.06 | 7.37 | 7.63 | 8.05 | 8.50 | 8.83 | 9.35 | 9.76 | 10.15 |
| Academic and Government Research Institutes | 10.42 | 10.86 | 11.29 | 11.60 | 12.36 | 13.20 | 13.58 | 14.36 | 15.10 | 15.43 | 16.11 |
| Biotechnology Companies | 5.47 | 5.54 | 5.87 | 6.06 | 6.32 | 6.59 | 6.73 | 7.20 | 7.40 | 8.16 | 8.20 |
| Contract Research Organizations | 5.86 | 6.15 | 6.36 | 6.94 | 7.36 | 7.67 | 8.36 | 8.71 | 9.34 | 9.85 | 10.37 |
| Other End-Users | 0.75 | 0.76 | 0.77 | 0.82 | 0.86 | 0.90 | 0.94 | 0.98 | 0.99 | 1.03 | 1.08 |
Clinical Trial Imaging Market Size By Region 2025 to (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 18.79 | 19.95 | 21.34 | 22.60 | 23.91 | 24.97 | 25.33 | 26.91 | 28.46 | 30.13 | 31.80 |
| Europe | 3.24 | 3.28 | 3.27 | 3.29 | 3.39 | 3.50 | 3.75 | 4.02 | 4.17 | 4.34 | 4.59 |
| Asia-Pacific | 5.55 | 5.78 | 5.93 | 6.32 | 6.71 | 7.08 | 7.62 | 7.83 | 8.37 | 8.39 | 8.78 |
| Latin America | 3.00 | 3.04 | 3.24 | 3.32 | 3.47 | 3.66 | 3.86 | 3.94 | 4.04 | 4.20 | 4.32 |
| Middle East and Africa | 6.65 | 6.93 | 7.02 | 7.18 | 7.24 | 7.59 | 8.43 | 8.58 | 8.65 | 9.14 | 9.32 |
Clinical Trial Imaging Market Size to Reach USD 5.45 Billion by 2034
The global clinical trial imaging market size was estimated at USD 2.57 billion in 2025 and is projected to be worth around USD 5.45 billion by 2034,with a CAGR of 8.78%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
